カテゴリー： 世界, 医療/バイオ, LP Information

世界の筋骨格系腫瘍治療市場予測 2023年-2029年

【英語タイトル】Global Musculoskeletal Tumor Treatment Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC03935）・商品コード：LP23DC03935
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：91
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の筋骨格系腫瘍治療市場」は、過去の販売実績から2022年の世界の筋骨格系腫瘍治療の総販売量を検討し、2023年から2029年の予測される筋骨格系腫瘍治療の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の筋骨格系腫瘍治療の市場規模を掲載し、XXX百万米ドル規模の世界の筋骨格系腫瘍治療市場の詳細な分析を提供します。本インサイトレポートは、世界の筋骨格系腫瘍治療業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の筋骨格系腫瘍治療市場における各社の独自のポジションをより深く理解するために、筋骨格系腫瘍治療製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の筋骨格系腫瘍治療市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。筋骨格系腫瘍治療の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。筋骨格系腫瘍治療の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。筋骨格系腫瘍治療のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

筋骨格系腫瘍治療の世界主要メーカーとしては、Stryker Corporation、 Accentus Inc.、 Roche Diagnostics、 Amgen Inc.、 Novartis AG、 Biogen dec、 GlaxoSmithKline、 Sanofi S.A.、 Pfizer Inc.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の筋骨格系腫瘍治療市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では筋骨格系腫瘍治療市場をセグメンテーションし、種類別 (手術、化学療法)、用途別 (病院、がん研究所、診断センター)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：手術、化学療法

・用途別区分：病院、がん研究所、診断センター

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の筋骨格系腫瘍治療市場の10年間の市場状況・展望は？
・世界および地域別に見た筋骨格系腫瘍治療市場成長の要因は何か？
・筋骨格系腫瘍治療の市場機会はエンドマーケットの規模によってどのように変化するのか？
・筋骨格系腫瘍治療のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：筋骨格系腫瘍治療の年間販売量2018-2029、地域別現状・将来分析
・筋骨格系腫瘍治療の種類別セグメント：手術、化学療法
・筋骨格系腫瘍治療の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・筋骨格系腫瘍治療の用途別セグメント：病院、がん研究所、診断センター
・筋骨格系腫瘍治療の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の筋骨格系腫瘍治療市場
・企業別のグローバル筋骨格系腫瘍治療市場データ：2018-2023年の年間販売量、市場シェア
・企業別の筋骨格系腫瘍治療の年間売上：2018-2023年の売上、市場シェア
・企業別の筋骨格系腫瘍治療販売価格
・主要企業の筋骨格系腫瘍治療生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

筋骨格系腫瘍治療の地域別レビュー
・地域別の筋骨格系腫瘍治療市場規模2018-2023：年間販売量、売上
・主要国別の筋骨格系腫瘍治療市場規模2018-2023：年間販売量、売上
・南北アメリカの筋骨格系腫瘍治療販売の成長
・アジア太平洋の筋骨格系腫瘍治療販売の成長
・ヨーロッパの筋骨格系腫瘍治療販売の成長
・中東・アフリカの筋骨格系腫瘍治療販売の成長

南北アメリカ市場
・南北アメリカの国別の筋骨格系腫瘍治療販売量、売上（2018-2023）
・南北アメリカの筋骨格系腫瘍治療の種類別販売量
・南北アメリカの筋骨格系腫瘍治療の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の筋骨格系腫瘍治療販売量、売上（2018-2023）
・アジア太平洋の筋骨格系腫瘍治療の種類別販売量
・アジア太平洋の筋骨格系腫瘍治療の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の筋骨格系腫瘍治療販売量、売上（2018-2023）
・ヨーロッパの筋骨格系腫瘍治療の種類別販売量
・ヨーロッパの筋骨格系腫瘍治療の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の筋骨格系腫瘍治療販売量、売上（2018-2023）
・中東・アフリカの筋骨格系腫瘍治療の種類別販売量
・中東・アフリカの筋骨格系腫瘍治療の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・筋骨格系腫瘍治療の製造コスト構造分析
・筋骨格系腫瘍治療の製造プロセス分析
・筋骨格系腫瘍治療の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・筋骨格系腫瘍治療の主要なグローバル販売業者
・筋骨格系腫瘍治療の主要なグローバル顧客

地域別の筋骨格系腫瘍治療市場予測レビュー
・地域別の筋骨格系腫瘍治療市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・筋骨格系腫瘍治療の種類別市場規模予測
・筋骨格系腫瘍治療の用途別市場規模予測

主要企業分析
Stryker Corporation、 Accentus Inc.、 Roche Diagnostics、 Amgen Inc.、 Novartis AG、 Biogen dec、 GlaxoSmithKline、 Sanofi S.A.、 Pfizer Inc.
・企業情報
・筋骨格系腫瘍治療製品
・筋骨格系腫瘍治療販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Musculoskeletal Tumor Treatment market size is projected to grow from US$ 1765.7 million in 2022 to US$ 2515.7 million in 2029; it is expected to grow at a CAGR of 5.2% from 2023 to 2029.
United States market for Musculoskeletal Tumor Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Musculoskeletal Tumor Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Musculoskeletal Tumor Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Musculoskeletal Tumor Treatment players cover Stryker Corporation, Accentus Inc., Roche Diagnostics, Amgen Inc., Novartis AG, Biogen dec, GlaxoSmithKline, Sanofi S.A. and Pfizer Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Musculoskeletal tumors are masses or lumps of tissue that develop in or spread to the musculoskeletal system as a result of abnormal and uncontrollable cell division. The musculoskeletal system includes the bones, joints, ligaments, muscles, and nerves.
LPI (LP Information)’ newest research report, the “Musculoskeletal Tumor Treatment Industry Forecast” looks at past sales and reviews total world Musculoskeletal Tumor Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Musculoskeletal Tumor Treatment sales for 2023 through 2029. With Musculoskeletal Tumor Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Musculoskeletal Tumor Treatment industry.
This Insight Report provides a comprehensive analysis of the global Musculoskeletal Tumor Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Musculoskeletal Tumor Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Musculoskeletal Tumor Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Musculoskeletal Tumor Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Musculoskeletal Tumor Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Musculoskeletal Tumor Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Surgery
Chemotherapy
Segmentation by application
Hospital
Cancer Research Institute
Diagnostic Center
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Stryker Corporation
Accentus Inc.
Roche Diagnostics
Amgen Inc.
Novartis AG
Biogen dec
GlaxoSmithKline
Sanofi S.A.
Pfizer Inc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Musculoskeletal Tumor Treatment market?
What factors are driving Musculoskeletal Tumor Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Musculoskeletal Tumor Treatment market opportunities vary by end market size?
How does Musculoskeletal Tumor Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Musculoskeletal Tumor Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Musculoskeletal Tumor Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Musculoskeletal Tumor Treatment by Country/Region, 2018, 2022 & 2029
2.2 Musculoskeletal Tumor Treatment Segment by Type
2.2.1 Surgery
2.2.2 Chemotherapy
2.3 Musculoskeletal Tumor Treatment Sales by Type
2.3.1 Global Musculoskeletal Tumor Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Musculoskeletal Tumor Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Musculoskeletal Tumor Treatment Sale Price by Type (2018-2023)
2.4 Musculoskeletal Tumor Treatment Segment by Application
2.4.1 Hospital
2.4.2 Cancer Research Institute
2.4.3 Diagnostic Center
2.5 Musculoskeletal Tumor Treatment Sales by Application
2.5.1 Global Musculoskeletal Tumor Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Musculoskeletal Tumor Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Musculoskeletal Tumor Treatment Sale Price by Application (2018-2023)
3 Global Musculoskeletal Tumor Treatment by Company
3.1 Global Musculoskeletal Tumor Treatment Breakdown Data by Company
3.1.1 Global Musculoskeletal Tumor Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Musculoskeletal Tumor Treatment Sales Market Share by Company (2018-2023)
3.2 Global Musculoskeletal Tumor Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Musculoskeletal Tumor Treatment Revenue by Company (2018-2023)
3.2.2 Global Musculoskeletal Tumor Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Musculoskeletal Tumor Treatment Sale Price by Company
3.4 Key Manufacturers Musculoskeletal Tumor Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Musculoskeletal Tumor Treatment Product Location Distribution
3.4.2 Players Musculoskeletal Tumor Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Musculoskeletal Tumor Treatment by Geographic Region
4.1 World Historic Musculoskeletal Tumor Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Musculoskeletal Tumor Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Musculoskeletal Tumor Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Musculoskeletal Tumor Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Musculoskeletal Tumor Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Musculoskeletal Tumor Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Musculoskeletal Tumor Treatment Sales Growth
4.4 APAC Musculoskeletal Tumor Treatment Sales Growth
4.5 Europe Musculoskeletal Tumor Treatment Sales Growth
4.6 Middle East & Africa Musculoskeletal Tumor Treatment Sales Growth
5 Americas
5.1 Americas Musculoskeletal Tumor Treatment Sales by Country
5.1.1 Americas Musculoskeletal Tumor Treatment Sales by Country (2018-2023)
5.1.2 Americas Musculoskeletal Tumor Treatment Revenue by Country (2018-2023)
5.2 Americas Musculoskeletal Tumor Treatment Sales by Type
5.3 Americas Musculoskeletal Tumor Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Musculoskeletal Tumor Treatment Sales by Region
6.1.1 APAC Musculoskeletal Tumor Treatment Sales by Region (2018-2023)
6.1.2 APAC Musculoskeletal Tumor Treatment Revenue by Region (2018-2023)
6.2 APAC Musculoskeletal Tumor Treatment Sales by Type
6.3 APAC Musculoskeletal Tumor Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Musculoskeletal Tumor Treatment by Country
7.1.1 Europe Musculoskeletal Tumor Treatment Sales by Country (2018-2023)
7.1.2 Europe Musculoskeletal Tumor Treatment Revenue by Country (2018-2023)
7.2 Europe Musculoskeletal Tumor Treatment Sales by Type
7.3 Europe Musculoskeletal Tumor Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Musculoskeletal Tumor Treatment by Country
8.1.1 Middle East & Africa Musculoskeletal Tumor Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Musculoskeletal Tumor Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Musculoskeletal Tumor Treatment Sales by Type
8.3 Middle East & Africa Musculoskeletal Tumor Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Musculoskeletal Tumor Treatment
10.3 Manufacturing Process Analysis of Musculoskeletal Tumor Treatment
10.4 Industry Chain Structure of Musculoskeletal Tumor Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Musculoskeletal Tumor Treatment Distributors
11.3 Musculoskeletal Tumor Treatment Customer
12 World Forecast Review for Musculoskeletal Tumor Treatment by Geographic Region
12.1 Global Musculoskeletal Tumor Treatment Market Size Forecast by Region
12.1.1 Global Musculoskeletal Tumor Treatment Forecast by Region (2024-2029)
12.1.2 Global Musculoskeletal Tumor Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Musculoskeletal Tumor Treatment Forecast by Type
12.7 Global Musculoskeletal Tumor Treatment Forecast by Application
13 Key Players Analysis
13.1 Stryker Corporation
13.1.1 Stryker Corporation Company Information
13.1.2 Stryker Corporation Musculoskeletal Tumor Treatment Product Portfolios and Specifications
13.1.3 Stryker Corporation Musculoskeletal Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Stryker Corporation Main Business Overview
13.1.5 Stryker Corporation Latest Developments
13.2 Accentus Inc.
13.2.1 Accentus Inc. Company Information
13.2.2 Accentus Inc. Musculoskeletal Tumor Treatment Product Portfolios and Specifications
13.2.3 Accentus Inc. Musculoskeletal Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Accentus Inc. Main Business Overview
13.2.5 Accentus Inc. Latest Developments
13.3 Roche Diagnostics
13.3.1 Roche Diagnostics Company Information
13.3.2 Roche Diagnostics Musculoskeletal Tumor Treatment Product Portfolios and Specifications
13.3.3 Roche Diagnostics Musculoskeletal Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Roche Diagnostics Main Business Overview
13.3.5 Roche Diagnostics Latest Developments
13.4 Amgen Inc.
13.4.1 Amgen Inc. Company Information
13.4.2 Amgen Inc. Musculoskeletal Tumor Treatment Product Portfolios and Specifications
13.4.3 Amgen Inc. Musculoskeletal Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Amgen Inc. Main Business Overview
13.4.5 Amgen Inc. Latest Developments
13.5 Novartis AG
13.5.1 Novartis AG Company Information
13.5.2 Novartis AG Musculoskeletal Tumor Treatment Product Portfolios and Specifications
13.5.3 Novartis AG Musculoskeletal Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novartis AG Main Business Overview
13.5.5 Novartis AG Latest Developments
13.6 Biogen dec
13.6.1 Biogen dec Company Information
13.6.2 Biogen dec Musculoskeletal Tumor Treatment Product Portfolios and Specifications
13.6.3 Biogen dec Musculoskeletal Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Biogen dec Main Business Overview
13.6.5 Biogen dec Latest Developments
13.7 GlaxoSmithKline
13.7.1 GlaxoSmithKline Company Information
13.7.2 GlaxoSmithKline Musculoskeletal Tumor Treatment Product Portfolios and Specifications
13.7.3 GlaxoSmithKline Musculoskeletal Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 GlaxoSmithKline Main Business Overview
13.7.5 GlaxoSmithKline Latest Developments
13.8 Sanofi S.A.
13.8.1 Sanofi S.A. Company Information
13.8.2 Sanofi S.A. Musculoskeletal Tumor Treatment Product Portfolios and Specifications
13.8.3 Sanofi S.A. Musculoskeletal Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sanofi S.A. Main Business Overview
13.8.5 Sanofi S.A. Latest Developments
13.9 Pfizer Inc.
13.9.1 Pfizer Inc. Company Information
13.9.2 Pfizer Inc. Musculoskeletal Tumor Treatment Product Portfolios and Specifications
13.9.3 Pfizer Inc. Musculoskeletal Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Pfizer Inc. Main Business Overview
13.9.5 Pfizer Inc. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Musculoskeletal Tumor Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Musculoskeletal Tumor Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Surgery
Table 4. Major Players of Chemotherapy
Table 5. Global Musculoskeletal Tumor Treatment Sales by Type (2018-2023) & (K Units)
Table 6. Global Musculoskeletal Tumor Treatment Sales Market Share by Type (2018-2023)
Table 7. Global Musculoskeletal Tumor Treatment Revenue by Type (2018-2023) & ($ million)
Table 8. Global Musculoskeletal Tumor Treatment Revenue Market Share by Type (2018-2023)
Table 9. Global Musculoskeletal Tumor Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Musculoskeletal Tumor Treatment Sales by Application (2018-2023) & (K Units)
Table 11. Global Musculoskeletal Tumor Treatment Sales Market Share by Application (2018-2023)
Table 12. Global Musculoskeletal Tumor Treatment Revenue by Application (2018-2023)
Table 13. Global Musculoskeletal Tumor Treatment Revenue Market Share by Application (2018-2023)
Table 14. Global Musculoskeletal Tumor Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Musculoskeletal Tumor Treatment Sales by Company (2018-2023) & (K Units)
Table 16. Global Musculoskeletal Tumor Treatment Sales Market Share by Company (2018-2023)
Table 17. Global Musculoskeletal Tumor Treatment Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Musculoskeletal Tumor Treatment Revenue Market Share by Company (2018-2023)
Table 19. Global Musculoskeletal Tumor Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Musculoskeletal Tumor Treatment Producing Area Distribution and Sales Area
Table 21. Players Musculoskeletal Tumor Treatment Products Offered
Table 22. Musculoskeletal Tumor Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Musculoskeletal Tumor Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Musculoskeletal Tumor Treatment Sales Market Share Geographic Region (2018-2023)
Table 27. Global Musculoskeletal Tumor Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Musculoskeletal Tumor Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Musculoskeletal Tumor Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Musculoskeletal Tumor Treatment Sales Market Share by Country/Region (2018-2023)
Table 31. Global Musculoskeletal Tumor Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Musculoskeletal Tumor Treatment Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Musculoskeletal Tumor Treatment Sales by Country (2018-2023) & (K Units)
Table 34. Americas Musculoskeletal Tumor Treatment Sales Market Share by Country (2018-2023)
Table 35. Americas Musculoskeletal Tumor Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Musculoskeletal Tumor Treatment Revenue Market Share by Country (2018-2023)
Table 37. Americas Musculoskeletal Tumor Treatment Sales by Type (2018-2023) & (K Units)
Table 38. Americas Musculoskeletal Tumor Treatment Sales by Application (2018-2023) & (K Units)
Table 39. APAC Musculoskeletal Tumor Treatment Sales by Region (2018-2023) & (K Units)
Table 40. APAC Musculoskeletal Tumor Treatment Sales Market Share by Region (2018-2023)
Table 41. APAC Musculoskeletal Tumor Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Musculoskeletal Tumor Treatment Revenue Market Share by Region (2018-2023)
Table 43. APAC Musculoskeletal Tumor Treatment Sales by Type (2018-2023) & (K Units)
Table 44. APAC Musculoskeletal Tumor Treatment Sales by Application (2018-2023) & (K Units)
Table 45. Europe Musculoskeletal Tumor Treatment Sales by Country (2018-2023) & (K Units)
Table 46. Europe Musculoskeletal Tumor Treatment Sales Market Share by Country (2018-2023)
Table 47. Europe Musculoskeletal Tumor Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Musculoskeletal Tumor Treatment Revenue Market Share by Country (2018-2023)
Table 49. Europe Musculoskeletal Tumor Treatment Sales by Type (2018-2023) & (K Units)
Table 50. Europe Musculoskeletal Tumor Treatment Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Musculoskeletal Tumor Treatment Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Musculoskeletal Tumor Treatment Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Musculoskeletal Tumor Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Musculoskeletal Tumor Treatment Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Musculoskeletal Tumor Treatment Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Musculoskeletal Tumor Treatment Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Musculoskeletal Tumor Treatment
Table 58. Key Market Challenges & Risks of Musculoskeletal Tumor Treatment
Table 59. Key Industry Trends of Musculoskeletal Tumor Treatment
Table 60. Musculoskeletal Tumor Treatment Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Musculoskeletal Tumor Treatment Distributors List
Table 63. Musculoskeletal Tumor Treatment Customer List
Table 64. Global Musculoskeletal Tumor Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Musculoskeletal Tumor Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Musculoskeletal Tumor Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Musculoskeletal Tumor Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Musculoskeletal Tumor Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Musculoskeletal Tumor Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Musculoskeletal Tumor Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Musculoskeletal Tumor Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Musculoskeletal Tumor Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Musculoskeletal Tumor Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Musculoskeletal Tumor Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Musculoskeletal Tumor Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Musculoskeletal Tumor Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Musculoskeletal Tumor Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Stryker Corporation Basic Information, Musculoskeletal Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 79. Stryker Corporation Musculoskeletal Tumor Treatment Product Portfolios and Specifications
Table 80. Stryker Corporation Musculoskeletal Tumor Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Stryker Corporation Main Business
Table 82. Stryker Corporation Latest Developments
Table 83. Accentus Inc. Basic Information, Musculoskeletal Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 84. Accentus Inc. Musculoskeletal Tumor Treatment Product Portfolios and Specifications
Table 85. Accentus Inc. Musculoskeletal Tumor Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Accentus Inc. Main Business
Table 87. Accentus Inc. Latest Developments
Table 88. Roche Diagnostics Basic Information, Musculoskeletal Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 89. Roche Diagnostics Musculoskeletal Tumor Treatment Product Portfolios and Specifications
Table 90. Roche Diagnostics Musculoskeletal Tumor Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Roche Diagnostics Main Business
Table 92. Roche Diagnostics Latest Developments
Table 93. Amgen Inc. Basic Information, Musculoskeletal Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 94. Amgen Inc. Musculoskeletal Tumor Treatment Product Portfolios and Specifications
Table 95. Amgen Inc. Musculoskeletal Tumor Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Amgen Inc. Main Business
Table 97. Amgen Inc. Latest Developments
Table 98. Novartis AG Basic Information, Musculoskeletal Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis AG Musculoskeletal Tumor Treatment Product Portfolios and Specifications
Table 100. Novartis AG Musculoskeletal Tumor Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Novartis AG Main Business
Table 102. Novartis AG Latest Developments
Table 103. Biogen dec Basic Information, Musculoskeletal Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 104. Biogen dec Musculoskeletal Tumor Treatment Product Portfolios and Specifications
Table 105. Biogen dec Musculoskeletal Tumor Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Biogen dec Main Business
Table 107. Biogen dec Latest Developments
Table 108. GlaxoSmithKline Basic Information, Musculoskeletal Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 109. GlaxoSmithKline Musculoskeletal Tumor Treatment Product Portfolios and Specifications
Table 110. GlaxoSmithKline Musculoskeletal Tumor Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. GlaxoSmithKline Main Business
Table 112. GlaxoSmithKline Latest Developments
Table 113. Sanofi S.A. Basic Information, Musculoskeletal Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 114. Sanofi S.A. Musculoskeletal Tumor Treatment Product Portfolios and Specifications
Table 115. Sanofi S.A. Musculoskeletal Tumor Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Sanofi S.A. Main Business
Table 117. Sanofi S.A. Latest Developments
Table 118. Pfizer Inc. Basic Information, Musculoskeletal Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 119. Pfizer Inc. Musculoskeletal Tumor Treatment Product Portfolios and Specifications
Table 120. Pfizer Inc. Musculoskeletal Tumor Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Pfizer Inc. Main Business
Table 122. Pfizer Inc. Latest Developments
List of Figures
Figure 1. Picture of Musculoskeletal Tumor Treatment
Figure 2. Musculoskeletal Tumor Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Musculoskeletal Tumor Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Musculoskeletal Tumor Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Musculoskeletal Tumor Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Surgery
Figure 10. Product Picture of Chemotherapy
Figure 11. Global Musculoskeletal Tumor Treatment Sales Market Share by Type in 2022
Figure 12. Global Musculoskeletal Tumor Treatment Revenue Market Share by Type (2018-2023)
Figure 13. Musculoskeletal Tumor Treatment Consumed in Hospital
Figure 14. Global Musculoskeletal Tumor Treatment Market: Hospital (2018-2023) & (K Units)
Figure 15. Musculoskeletal Tumor Treatment Consumed in Cancer Research Institute
Figure 16. Global Musculoskeletal Tumor Treatment Market: Cancer Research Institute (2018-2023) & (K Units)
Figure 17. Musculoskeletal Tumor Treatment Consumed in Diagnostic Center
Figure 18. Global Musculoskeletal Tumor Treatment Market: Diagnostic Center (2018-2023) & (K Units)
Figure 19. Global Musculoskeletal Tumor Treatment Sales Market Share by Application (2022)
Figure 20. Global Musculoskeletal Tumor Treatment Revenue Market Share by Application in 2022
Figure 21. Musculoskeletal Tumor Treatment Sales Market by Company in 2022 (K Units)
Figure 22. Global Musculoskeletal Tumor Treatment Sales Market Share by Company in 2022
Figure 23. Musculoskeletal Tumor Treatment Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Musculoskeletal Tumor Treatment Revenue Market Share by Company in 2022
Figure 25. Global Musculoskeletal Tumor Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Musculoskeletal Tumor Treatment Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Musculoskeletal Tumor Treatment Sales 2018-2023 (K Units)
Figure 28. Americas Musculoskeletal Tumor Treatment Revenue 2018-2023 ($ Millions)
Figure 29. APAC Musculoskeletal Tumor Treatment Sales 2018-2023 (K Units)
Figure 30. APAC Musculoskeletal Tumor Treatment Revenue 2018-2023 ($ Millions)
Figure 31. Europe Musculoskeletal Tumor Treatment Sales 2018-2023 (K Units)
Figure 32. Europe Musculoskeletal Tumor Treatment Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Musculoskeletal Tumor Treatment Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Musculoskeletal Tumor Treatment Revenue 2018-2023 ($ Millions)
Figure 35. Americas Musculoskeletal Tumor Treatment Sales Market Share by Country in 2022
Figure 36. Americas Musculoskeletal Tumor Treatment Revenue Market Share by Country in 2022
Figure 37. Americas Musculoskeletal Tumor Treatment Sales Market Share by Type (2018-2023)
Figure 38. Americas Musculoskeletal Tumor Treatment Sales Market Share by Application (2018-2023)
Figure 39. United States Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Musculoskeletal Tumor Treatment Sales Market Share by Region in 2022
Figure 44. APAC Musculoskeletal Tumor Treatment Revenue Market Share by Regions in 2022
Figure 45. APAC Musculoskeletal Tumor Treatment Sales Market Share by Type (2018-2023)
Figure 46. APAC Musculoskeletal Tumor Treatment Sales Market Share by Application (2018-2023)
Figure 47. China Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Musculoskeletal Tumor Treatment Sales Market Share by Country in 2022
Figure 55. Europe Musculoskeletal Tumor Treatment Revenue Market Share by Country in 2022
Figure 56. Europe Musculoskeletal Tumor Treatment Sales Market Share by Type (2018-2023)
Figure 57. Europe Musculoskeletal Tumor Treatment Sales Market Share by Application (2018-2023)
Figure 58. Germany Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Musculoskeletal Tumor Treatment Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Musculoskeletal Tumor Treatment Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Musculoskeletal Tumor Treatment Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Musculoskeletal Tumor Treatment Sales Market Share by Application (2018-2023)
Figure 67. Egypt Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Musculoskeletal Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Musculoskeletal Tumor Treatment in 2022
Figure 73. Manufacturing Process Analysis of Musculoskeletal Tumor Treatment
Figure 74. Industry Chain Structure of Musculoskeletal Tumor Treatment
Figure 75. Channels of Distribution
Figure 76. Global Musculoskeletal Tumor Treatment Sales Market Forecast by Region (2024-2029)
Figure 77. Global Musculoskeletal Tumor Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Musculoskeletal Tumor Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Musculoskeletal Tumor Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Musculoskeletal Tumor Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Musculoskeletal Tumor Treatment Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の筋骨格系腫瘍治療市場予測 2023年-2029年] (コード：LP23DC03935)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の筋骨格系腫瘍治療市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の腫瘍凍結アブレーション装置市場予測 2023年-2029年
  • 世界の腫瘍マイクロ波アブレーション装置市場予測 2023年-2029年
  • 世界の腫瘍免疫チェックポイント阻害剤療法市場予測 2023年-2029年
  • 世界の腫瘍用高周波治療機市場予測 2023年-2029年
  • 世界の腫瘍セルソーター市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆